$2995 | Single User
$4495 | Multi User
$8995 | Site License
$14995 | Global License

Global Sexual Health Partnering 2010-2017: Deal trends, players and financials [Report Updated: 01-11-2017]

Published by Current Partnering: 01 Nov 2017 | 133413 | In Stock

Introduction

Global Sexual Health Partnering 2010 to 2017 provides the full collection of Sexual Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.


Trends in Sexual Health partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Sexual Health partnering agreement structure

Sexual Health partnering contract documents

Top Sexual Health deals by value

Most active Sexual Health dealmakers


Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.


The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.


The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.


The initial chapters of this report provide an orientation of Sexual Health dealmaking trends.


Chapter 1 provides an introduction to the report.


Chapter 2 provides an overview of the trends in Sexual Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.


Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.


Chapter 4 provides a review of the leading Sexual Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Sexual Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 5 provides comprehensive access to Sexual Health deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive directory of all Sexual Health partnering deals by specific Sexual Health target announced since 2010. The chapter is organized by specific Sexual Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


In addition, a comprehensive appendix is provided with each report of all Sexual Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in Sexual Health partnering and dealmaking since 2010.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Sexual Health technologies and products.


Report scope


Global Sexual Health Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Sexual Health trends and structure of deals entered into by leading companies worldwide.


Global Sexual Health Partnering 2010 to 2017 includes:


Trends in Sexual Health dealmaking in the biopharma industry since 2010

Analysis of Sexual Health deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Sexual Health deal contract documents

Comprehensive access to over 3500 Sexual Health deal records

The leading Sexual Health deals by value since 2010

Most active Sexual Health dealmakers since 2010


The report includes deals for the following indications: Bacterial vaginosis, Candida albicans (Thrush), Contraception, Erectile dysfunction, Sexual dysfunction, Sexually transmitted disease (STI), Chlamydia, Genital warts, Gonorrhea, Herpes, Syphilis, Trichomoniasis, plus other sexual health indications.


In Global Sexual Health Partnering 2010 to 2017, available deals and contracts are listed by:


Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Sexual Health Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 100 sexual health deals. Analyzing actual contract agreements allows assessment of the following:


What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Table of Contents
for Global Sexual Health Partnering 2010-2017: Deal trends, players and financials [Report Updated: 01-11-2017]

  • Executive Summary

    Chapter 1 – Introduction

    Chapter 2 – Trends in Sexual Health dealmaking

    2.1. Introduction

    2.2. Sexual Health partnering over the years

    2.3. Sexual Health partnering by deal type

    2.4. Sexual Health partnering by industry sector

    2.5. Sexual Health partnering by stage of development

    2.6. Sexual Health partnering by technology type

    2.7. Sexual Health partnering by therapeutic indication

    Chapter 3 –Financial deal terms for Sexual Health partnering

    3.1. Introduction

    3.2. Disclosed financials terms for Sexual Health partnering

    3.3. Sexual Health partnering headline values

    3.4. Sexual Health deal upfront payments

    3.5. Sexual Health deal milestone payments

    3.6. Sexual Health royalty rates

    Chapter 4 – Leading Sexual Health deals and dealmakers

    4.1. Introduction

    4.2. Most active in Sexual Health partnering

    4.3. List of most active dealmakers in Sexual Health

    4.4. Top Sexual Health deals by value

    Chapter 5 – Sexual Health contract document directory

    5.1. Introduction

    5.2. Sexual Health partnering deals where contract document available

    Chapter 6 – Sexual Health dealmaking by therapeutic target

    6.1. Introduction

    6.2. Deals by Sexual Health therapeutic target

    Appendices

    Appendix 1 – Directory of Sexual Health deals by company A-Z 2010 to 2017

    Appendix 2 – Directory of Sexual Health deals by deal type 2010 to 2017

    Appendix 3 – Directory of Sexual Health deals by stage of development 2010 to 2017

    Appendix 4 – Directory of Sexual Health deals by technology type 2010 to 2017

    Further reading on dealmaking

    Deal type definitions

    About Wildwood Ventures

    Current Partnering

    Current Agreements

    Recent report titles from CurrentPartnering

    Table of figures

    Figure 1: Sexual Health partnering since 2010

    Figure 2: Sexual Health partnering by deal type since 2010

    Figure 3: Sexual Health partnering by industry sector since 2010

    Figure 4: Sexual Health partnering by stage of development since 2010

    Figure 5: Sexual Health partnering by technology type since 2010

    Figure 6: Sexual Health partnering by indication since 2010

    Figure 7: Sexual Health deals with a headline value

    Figure 8: Sexual Health deals with upfront payment values

    Figure 9: Sexual Health deals with milestone payment

    Figure 10: Sexual Health deals with royalty rates

    Figure 11: Active Sexual Health dealmaking activity– 2010 to 2017

    Figure 12: Top Sexual Health deals by value since 2010

Additional Details

Publisher

Current Partnering

Publisher Information

Reference

133413 | CP2212

Number of Pages

250

Report Format

PDF

Current Partnering Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Sexual Health Partnering 2010-2017: Deal trends, players and financials
Global Sexual Health Partnering 2010 to 2017 provides the full collection of Sexual Health disease d...
01 Feb 2017 by Current Partnering USD $2,995 More Info
Global Sexual Dysfunction Partnering 2010 to 2017
The Global Sexual Dysfunction Partnering Terms and Agreements since 2010 report provides understandi...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Female Sexual Dysfunction - Pipeline Review, H2 2016
Female Sexual Dysfunction - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceut...
21 Dec 2016 by Global Markets Direct USD $2,000 More Info
Global Sexual Health Partnering 2010-2016: Deal trends, players and financials
Global Sexual Health Partnering 2010 to 2016 provides the full collection of Sexual Health disease d...
01 Nov 2016 by Current Partnering USD $2,995 More Info
Global Sexual Dysfunction Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Sexual Health Partnering 2010-2016: Deal trends, players and financials
Global Sexual Health Partnering 2010 to 2016 provides the full collection of Sexual Health disease d...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Global Sexual Dysfunction Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial ...
04 Dec 2015 by Global Data USD $2,500 More Info
Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2015
Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2015SummaryGlobalData's ...
04 Dec 2015 by Global Data USD $2,500 More Info
Global Sexual Wellness Market 2015-2019
About Sexual WellnessSexual wellness is a term used to describe the enhancement of sexual health and...
25 Feb 2015 by Technavio USD $3,000 More Info

This report is published by Current Partnering

Download Free Report Summary PDF

Global Sexual Health Partnering 2010-2017: Deal trends, players and financials [Report Updated: 01-11-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data